Tuberculosis in times of COVID-19.
COVID-19
health services
public health
tuberculosis
Journal
Journal of epidemiology and community health
ISSN: 1470-2738
Titre abrégé: J Epidemiol Community Health
Pays: England
ID NLM: 7909766
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
21
06
2021
accepted:
02
09
2021
pubmed:
19
9
2021
medline:
16
2
2022
entrez:
18
9
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic has caused widespread disruptions to tuberculosis (TB) care and service delivery in 2020, setting back progress in the fight against TB by several years. As newer COVID-19 variants continue to devastate many low and middle-income countries in 2021, the extent of this setback is likely to increase. Despite these challenges, the TB community can draw on the comprehensive approaches used to manage COVID-19 to help restore progress and mitigate the impact of COVID-19 on TB. Our team developed the 'Swiss Cheese Model for Ending TB' to illustrate that it is only through multisectoral collaborations that address the personal, societal and health system layers of care that we will end TB. In this paper, we examine how COVID-19 has impacted the different layers of TB care presented in the model and explore how we can leverage some of the lessons and outcomes of the COVID-19 pandemic to strengthen the global TB response.
Identifiants
pubmed: 34535539
pii: jech-2021-217529
doi: 10.1136/jech-2021-217529
pmc: PMC8453591
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
310-316Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: MP serves as an advisor to the Bill & Melinda Gates Foundation, WHO Stop TB Partnership and Foundation for Innovative New Diagnostics.
Références
Int J Tuberc Lung Dis. 2020 Jun 1;24(6):642-643
pubmed: 32552997
Pulmonology. 2021 Jul-Aug;27(4):338-344
pubmed: 33648891
Int J Epidemiol. 2010 Feb;39(1):149-55
pubmed: 19820104
Cochrane Database Syst Rev. 2020 Apr 21;4:CD013582
pubmed: 32315451
Int J Tuberc Lung Dis. 2021 May 1;25(5):409-412
pubmed: 33977912
Health Policy Plan. 2020 Oct 1;35(8):1130-1132
pubmed: 32832996
MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):971-972
pubmed: 32701944
Int J Tuberc Lung Dis. 2021 May 1;25(5):406-408
pubmed: 33977911
PLoS One. 2015 Mar 25;10(3):e0119861
pubmed: 25806955
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
PLoS One. 2021 Feb 2;16(2):e0244936
pubmed: 33529206
J Clin Tuberc Other Mycobact Dis. 2021 Jun 25;24:100248
pubmed: 34189276
Diabetes Res Clin Pract. 2020 Aug;166:108347
pubmed: 32711003
Lancet. 2002 Mar 2;359(9308):775-80
pubmed: 11888605
Sci Rep. 2021 Mar 18;11(1):6283
pubmed: 33737527
J Clin Tuberc Other Mycobact Dis. 2021 Jan 07;23:100212
pubmed: 34095545
Sci Rep. 2021 Feb 4;11(1):3134
pubmed: 33542443
EClinicalMedicine. 2020 Oct 24;28:100603
pubmed: 33134905
Lancet Microbe. 2021 May;2(5):e169-e170
pubmed: 33778790
Lancet Respir Med. 2020 Sep;8(9):844-846
pubmed: 32758439
Antibiotics (Basel). 2021 Mar 08;10(3):
pubmed: 33800406
Int J Infect Dis. 2021 Dec;113 Suppl 1:S88-S90
pubmed: 33744479
Lancet Respir Med. 2021 Apr;9(4):340-342
pubmed: 33493446
Lancet HIV. 2021 Mar;8(3):e158-e165
pubmed: 33549166
J Clin Tuberc Other Mycobact Dis. 2020 Dec;21:100199
pubmed: 33163631
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Lancet Glob Health. 2020 Sep;8(9):e1132-e1141
pubmed: 32673577
N Engl J Med. 2019 Dec 19;381(25):2429-2439
pubmed: 31661198
Public Health Action. 2020 Dec 21;10(4):157-162
pubmed: 33437681
J Infect. 2017 Dec;75(6):499-510
pubmed: 28941629
Int J Tuberc Lung Dis. 2021 Jun 1;25(6):436-446
pubmed: 34049605
BMJ Glob Health. 2020 Nov;5(11):
pubmed: 33199280
Sci Rep. 2018 Oct 17;8(1):15309
pubmed: 30333506
Expert Opin Biol Ther. 2012 Dec;12(12):1601-10
pubmed: 22957516
Eur Respir J. 2020 Oct 22;56(4):
pubmed: 32978310
Expert Rev Respir Med. 2021 Jul;15(7):867-883
pubmed: 33016808
Clin Infect Dis. 2021 Oct 5;73(7):e2005-e2015
pubmed: 32860699
J Clin Tuberc Other Mycobact Dis. 2021 Dec;25:100277
pubmed: 34545343
Lancet Child Adolesc Health. 2021 Mar;5(3):159-161
pubmed: 33609490
BMJ Open Qual. 2019 Mar 1;8(1):
pubmed: 30997408
J Clin Tuberc Other Mycobact Dis. 2020 Feb 26;19:100155
pubmed: 32211519
Vaccine. 2020 Oct 21;38(45):7146-7155
pubmed: 32943265